<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>HB 879 (Edition 1)</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Times New \(W1\)";}
@font-face
	{font-family:IDAutomationHC39M;
	panose-1:2 0 5 9 0 0 0 2 0 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.25pt;
	margin-bottom:.0001pt;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:23.75pt;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.MsoLineNumber
	{font-family:"Times New Roman",serif;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-link:"Plain Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.LMSBase, li.LMSBase, div.LMSBase
	{mso-style-name:LMSBase;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticle, li.aArticle, div.aArticle
	{mso-style-name:aArticle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aArticleTitle, li.aArticleTitle, div.aArticleTitle
	{mso-style-name:aArticleTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBase, li.aBase, div.aBase
	{mso-style-name:aBase;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBillSection, li.aBillSection, div.aBillSection
	{mso-style-name:aBillSection;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock1, li.aBlock1, div.aBlock1
	{mso-style-name:aBlock1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock2, li.aBlock2, div.aBlock2
	{mso-style-name:aBlock2;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock3, li.aBlock3, div.aBlock3
	{mso-style-name:aBlock3;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock4, li.aBlock4, div.aBlock4
	{mso-style-name:aBlock4;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aBlock5, li.aBlock5, div.aBlock5
	{mso-style-name:aBlock5;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:3.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aChapter, li.aChapter, div.aChapter
	{mso-style-name:aChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aHeading, li.aHeading, div.aHeading
	{mso-style-name:aHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aLongTitle, li.aLongTitle, div.aLongTitle
	{mso-style-name:aLongTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;}
p.aMargin1, li.aMargin1, div.aMargin1
	{mso-style-name:aMargin1;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aMargin2, li.aMargin2, div.aMargin2
	{mso-style-name:aMargin2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aPart, li.aPart, div.aPart
	{mso-style-name:aPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSection, li.aSection, div.aSection
	{mso-style-name:aSection;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSP, li.aSP, div.aSP
	{mso-style-name:aSP;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:blue;
	font-weight:bold;}
p.aSPComment, li.aSPComment, div.aSPComment
	{mso-style-name:aSPComment;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	color:red;
	display:none;
	font-weight:bold;}
p.aSPFunds1, li.aSPFunds1, div.aSPFunds1
	{mso-style-name:aSPFunds1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFunds2, li.aSPFunds2, div.aSPFunds2
	{mso-style-name:aSPFunds2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPFundsHeading1, li.aSPFundsHeading1, div.aSPFundsHeading1
	{mso-style-name:aSPFundsHeading1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPFundsHeading2, li.aSPFundsHeading2, div.aSPFundsHeading2
	{mso-style-name:aSPFundsHeading2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.aSPHeading, li.aSPHeading, div.aSPHeading
	{mso-style-name:aSPHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.nonumber, li.nonumber, div.nonumber
	{mso-style-name:nonumber;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPHeadingLine, li.aSPHeadingLine, div.aSPHeadingLine
	{mso-style-name:aSPHeadingLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.ASPlist, li.ASPlist, div.ASPlist
	{mso-style-name:ASPlist;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.5in;
	margin-bottom:.0001pt;
	text-indent:-1.75in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aSPRequestedBY, li.aSPRequestedBY, div.aSPRequestedBY
	{mso-style-name:aSPRequestedBY;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";}
p.aSPTitle, li.aSPTitle, div.aSPTitle
	{mso-style-name:aSPTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New \(W1\)";
	text-transform:uppercase;
	font-weight:bold;}
p.aSubChapter, li.aSubChapter, div.aSubChapter
	{mso-style-name:aSubChapter;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSubPart, li.aSubPart, div.aSubPart
	{mso-style-name:aSubPart;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.aTitle, li.aTitle, div.aTitle
	{mso-style-name:aTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.cHistoryNote
	{mso-style-name:cHistoryNote;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
p.TOCPageHeader, li.TOCPageHeader, div.TOCPageHeader
	{mso-style-name:TOCPageHeader;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPSubTitle, li.aSPSubTitle, div.aSPSubTitle
	{mso-style-name:aSPSubTitle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aSPHeadingMiscellaneous, li.aSPHeadingMiscellaneous, div.aSPHeadingMiscellaneous
	{mso-style-name:aSPHeadingMiscellaneous;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	text-transform:uppercase;
	font-weight:bold;}
p.aDistrict, li.aDistrict, div.aDistrict
	{mso-style-name:aDistrict;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-link:"Plain Text";
	font-family:"Calibri",sans-serif;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:10.0pt;
	line-height:115%;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:.6in .9in .5in 1.2in;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=nonumber align=center style='margin-top:24.0pt;text-align:center'><b>GENERAL
ASSEMBLY OF NORTH CAROLINA</b></p>

<p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
margin-bottom:6.0pt;margin-left:0in;text-align:center'><b>SESSION 2019</b></p>

<p class=nonumber align=left style='text-align:left'><b>H                                                                                                                                                    1</b></p>

<p class=nonumber align=center style='text-align:center'><b>HOUSE BILL 879</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<p class=nonumber align=center style='text-align:center'><b>&nbsp;</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=0
 style='width:6.55in;margin-left:-5.75pt;border-collapse:collapse;border:none'>
 <tr>
  <td width=527 colspan=2 valign=top style='width:395.25pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-bottom:6.0pt;text-align:left'>Short
  Title:      End of Life Option Act.</p>
  </td>
  <td width=102 valign=top style='width:76.35pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=right style='margin-bottom:6.0pt;text-align:right'>(Public)</p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Sponsors:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Representatives
  Harrison, Hardister, McGrady, and Fisher (Primary Sponsors).</p>
  <p class=nonumber align=center style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:center'><i><span
  style='font-size:10.0pt'>For a complete list of sponsors, refer to the North
  Carolina General Assembly web site.</span></i></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top style='width:71.85pt;border:none;border-bottom:solid windowtext 1.0pt;
  padding:0in .05in 0in 5.4pt'>
  <p class=nonumber align=left style='margin-top:3.0pt;margin-right:0in;
  margin-bottom:3.0pt;margin-left:0in;text-align:left'>Referred to:</p>
  </td>
  <td width=533 colspan=2 valign=top style='width:399.75pt;border:none;
  border-bottom:solid windowtext 1.0pt;padding:0in .05in 0in 5.4pt'>
  <p class=nonumber style='margin-top:3.0pt;margin-right:0in;margin-bottom:
  3.0pt;margin-left:0in'>Rules, Calendar, and Operations of the House</p>
  </td>
 </tr>
 <tr height=0>
  <td width=96 style='border:none'></td>
  <td width=431 style='border:none'></td>
  <td width=102 style='border:none'></td>
 </tr>
</table>

<p class=nonumber align=center style='margin-top:6.0pt;margin-right:0in;
margin-bottom:12.0pt;margin-left:0in;text-align:center'>April 22, 2019</p>

<p class=aBase align=center style='text-align:center'><span style='color:black'>A
BILL TO BE ENTITLED</span></p>

<p class=aLongTitle><span style='font-family:"Times New Roman",serif;
color:black'>AN ACT establishing aN end of life option act to allow qualified
patients diagnosed with a terminal disease to end life in a humane and
dignified manner.</span></p>

<p class=aBase><span style='color:black'>The General Assembly of North Carolina
enacts:</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 1.</span></b><span
style='color:black'>  Chapter 90 of the General Statutes is amended by adding a
new Article to read:</span></p>

<p class=aArticle><span style='color:black'>&quot;<u>Article 23B.</u></span></p>

<p class=aArticleTitle><span style='color:black'>&quot;<u>End of Life Option
Act.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.  Definitions.</span></u></p>

<p class=aMargin1><u><span style='color:black'>The following definitions apply
in this Article:</span></u></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Adult. – An individual who is 18 years of age or
older.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Attending physician. – A North Carolina licensed
physician who meets the following requirements: (i) has established a bona fide
physician&#8209;patient relationship with an individual with a terminal disease,
(ii) has the requisite experience to confirm the individual's terminal disease
diagnosis and to fulfill the responsibilities of an attending physician under
this Article, and (iii) has primary responsibility for supervising the individual's
terminal disease under the provisions of this Article. The attending physician
need not be the individual's primary care physician.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Attending Physician Checklist and Compliance Form.
– The form published by the Department pursuant to G.S.&nbsp;90&#8209;326.17 identifying
each and every requirement that must be fulfilled by an attending physician in
order to be in good&#8209;faith compliance with this Article if the attending
physician chooses to participate in the activities authorized under this
Article.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Attending witness. – An individual nominated by
the qualified individual to be present if and when the qualified individual
self&#8209;administers the terminal comfort care drug and who undertakes to (i)
complete the Attending Witness Completion Form confirming self&#8209;administration
of the terminal comfort care drug and the death of the qualified individual and
(ii) return the Attending Witness Completion Form to the attending physician
within 48 hours after the death of the qualified individual. The attending
witness may, but need not, be (i) related to the qualified individual by blood,
adoption, or marriage, or (ii) a health care provider. At the discretion of the
qualified individual, the attending witness may be the attending physician.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Bona fide physician&#8209;patient relationship.
– A treating relationship in the course of which a physician has completed an
assessment of a patient's medical history and current medical condition,
including a personal physical examination.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Capacity to make medical decisions. – In the
opinion of an individual's attending physician, psychiatrist, or psychologist,
the individual has the ability to understand the nature and consequences of a
health care decision; the ability to understand its significant benefits,
risks, and alternatives; and the ability to make and communicate an informed
decision to health care providers, including communication through persons
familiar with the qualified individual's manner or language of communication,
if those persons are required.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>Department. – The North Carolina Department of
Health and Human Services.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>Health care provider or provider of health care.
– An individual who is licensed, certified, or otherwise authorized under
Chapter 90 of the General Statutes to provide health care services in the
ordinary course of business or practice of a profession or a health care
facility licensed under Chapter 131E of the General Statutes, where health care
services are provided to patients. The term includes all of the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>An agent or employee of a health care facility
that is licensed, certified, or otherwise authorized to provide health care
services.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>The officers and directors of a health care
facility.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>An agent or employee of a health care provider
who is licensed, certified, or otherwise authorized to provide health care
services.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(9)</span></u><span
style='color:black'>        <u>Hospice. – As defined in G.S.&nbsp;131E&#8209;176(13a).</u></span></p>

<p class=aBlock1><u><span style='color:black'>(10)</span></u><span
style='color:black'>      <u>Hospice evaluation. – A written assessment by a
qualified hospice physician or a qualified hospice nurse practitioner of an
individual's eligibility for hospice, regardless of whether the individual
meets the criteria for admission into hospice. The term includes a
certification of terminal illness that meets the requirements of 42 C.F.R. § 418.22.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(11)</span></u><span
style='color:black'>      <u>Informed decision. – A decision by an individual
with a terminal disease to request and obtain a prescription for a terminal
comfort care drug that the individual may self&#8209;administer to hasten the
individual's death, that is based on an understanding and acknowledgement of
the relevant facts, and that is made after being fully informed by the
attending physician of all of the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>The individual's medical diagnosis and
prognosis.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>The risks associated with taking the terminal
comfort care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>The probable result of taking the terminal
comfort care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>The right of the individual to change his or
her mind at any time by discontinuing proceedings under this Article and by
choosing not to obtain the terminal comfort care drug or, after obtaining the terminal
comfort care drug, by deciding not to proceed with self&#8209;administration.</u></span></p>

<p class=aBlock2><u><span style='color:black'>e.</span></u><span
style='color:black'>         <u>The feasible alternatives or additional end&#8209;of&#8209;life
options.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(12)</span></u><span
style='color:black'>      <u>Mental health specialist assessment. – One or more
consultations between an individual and a mental health specialist for the
purpose of determining that the individual has the capability to make medical
decisions and is not suffering from impaired judgment.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(13)</span></u><span
style='color:black'>      <u>Mental health specialist. – A psychiatrist or a
psychologist licensed to practice in North Carolina.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(14)</span></u><span
style='color:black'>      <u>Physician. – An individual licensed to practice
medicine by the North Carolina Medical Board under Article 1 of Chapter 90 of
the General Statutes.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(15)</span></u><span
style='color:black'>      <u>Public place. – Any street, alley, park, public
building, place of business, or assembly open to or frequented by the public,
and any other place that is open to the public view or to which the public has
access.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(16)</span></u><span
style='color:black'>      <u>Qualified individual. – An adult who meets all of
the following qualifications:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>Is a resident of North Carolina.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>Has the capacity to make medical decisions and
to self&#8209;administer drugs.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>Has undergone a hospice evaluation.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>Has satisfied the requirements of this Article
in order to obtain a prescription for a terminal comfort care drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(17)</span></u><span
style='color:black'>      <u>Self&#8209;administer. – A qualified individual's
affirmative, voluntary, conscious, and physical act of administering and self&#8209;administering
the terminal comfort care drug to hasten death.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(18)</span></u><span
style='color:black'>      <u>Terminal comfort care drug. – A controlled
substance determined and prescribed by a physician licensed in this State for a
qualified individual with the purpose of hastening the qualified individual's death
due to a terminal disease.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(19)</span></u><span
style='color:black'>      <u>Terminal disease. – An incurable and irreversible
disease that, having previously been determined, has been medically confirmed
by the attending physician and will, within reasonable medical judgment, result
in death within six months.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.1.  Right to information.</span></u></p>

<p class=aMargin1><u><span style='color:black'>An individual suffering from an
incurable, terminal disease has a right to be informed of all available end&#8209;of&#8209;life
options related to terminal care and to receive answers to any specific
question about the foreseeable risks and benefits of medication without the
physician withholding any requested information, regardless of the purpose of
the inquiry or the nature of the information. A physician who engages in
discussions with a patient related to such risks and benefits shall not be
construed as assisting in or contributing to a patient's independent decision
to self&#8209;administer a lethal dose of medication, and such discussions
shall not be used to establish civil or criminal liability or professional
disciplinary action.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.2.  Initiation of request for terminal
comfort care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>An individual who is an adult with the capacity
to make medical decisions suffering from an incurable, terminal disease may
make a request to receive a prescription for a terminal comfort care drug,
provided that all of the following conditions are satisfied:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>The individual has undergone a hospice
evaluation.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>The individual's attending physician has
diagnosed the individual to be suffering from an incurable, terminal disease.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The individual has voluntarily expressed
verbally and in writing the wish to receive a prescription for a terminal
comfort care drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>The individual is a resident of North Carolina.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>The individual documents his or her request
pursuant to the requirements of G.S.&nbsp;90&#8209;326.3 and on the form specified
in G.S.&nbsp;90&#8209;326.3A.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>The individual has the physical and mental
ability to self&#8209;administer the terminal comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>A person shall not be considered a qualified
individual under the provisions of this Article solely because of age or
disability.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>A request for a prescription for a terminal
comfort care drug under this Article shall be made solely and directly by the
individual diagnosed with the terminal disease and shall not be made on behalf
of the patient, including through an advance health care directive or a power
of attorney, conservator, health care agent, surrogate, or any other legally
recognized health care decision maker.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.3.  Form of request for terminal comfort
care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>An individual seeking to obtain a prescription
for a terminal comfort care drug pursuant to this Article shall make a verbal
request, followed by a written request no later than 10 days after the verbal
request, that meets the requirements of subsection (b) of this section directly
to his or her attending physician and not to a designee of the physician. The
attending physician shall directly, and not through a designee, receive all
requests required by this section. The attending physician shall keep records
of the verbal and written requests in the individual's medical file. The record
of any verbal request must include the date and time of the request as well as
a summary of the request.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>In order to be valid, a written request for a terminal
comfort care drug must meet all of the following criteria:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>The request shall be in the form specified in G.S.&nbsp;90&#8209;326.3A.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>The request shall be signed and dated by the
individual seeking the terminal comfort care drug in the presence of two adult
witnesses, who, in the presence of the individual, shall attest that to the
best of their knowledge and belief the individual is all of the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>An individual who is personally known to them
or has provided proof of identity.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>An individual who voluntarily signed this
request in their presence.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>An individual whom they believe to be mentally
capable and not acting under duress, fraud, or undue influence.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>An individual for whom not more than one of
them is the attending physician or mental health specialist.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.3A.  Request for Terminal Comfort Care Drug Form.</span></u></p>

<p class=aMargin1><u><span style='color:black'>A request for a terminal comfort
care drug, as authorized by this Article, shall be in the following form:</span></u></p>

<p class=aMargin1><span style='color:black'>&quot;<u>REQUEST FOR A TERMINAL
COMFORT CARE DRUG TO END MY LIFE IN A HUMANE AND DIGNIFIED MANNER</u></span></p>

<p class=aMargin1><u><span style='color:black'>I, ………………………………………………, am an
adult of sound mind and a resident of the State of North Carolina.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I have been diagnosed as
suffering from ……………., which my attending physician has determined is in its
terminal phase and which has been medically confirmed as leaving me less than
six months to live.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I have undergone a hospice
evaluation and released the records of that evaluation to my attending
physician.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I have been fully informed of my
diagnosis and prognosis, the nature of the terminal comfort care drug to be
prescribed and potential associated risks, the expected result, and the feasible
alternatives or additional treatment options.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I request that my attending
physician prescribe a terminal comfort care drug that will end my life in a
humane and dignified manner if I choose to take it, and I authorize my
attending physician to contact my pharmacist about my request.</span></u></p>

<p class=aMargin1><u><span style='color:black'>INITIAL ONE:</span></u></p>

<p class=aMargin1><u><span style='color:black'>………… I have informed one or more
members of my family of my decision and have taken their opinions into
consideration.</span></u></p>

<p class=aMargin1><u><span style='color:black'>………… I have decided not to
inform my family of my decision.</span></u></p>

<p class=aMargin1><u><span style='color:black'>………… I have no family to inform
of my decision.</span></u></p>

<p class=aMargin1><u><span style='color:black'>INITIAL ONE:</span></u></p>

<p class=aMargin1><u><span style='color:black'>………… I nominate ……………… to be my
attending witness should I decide to self&#8209;administer the prescribed terminal
comfort care drug and authorize ……………… to transmit the final confirmation of my
death by self&#8209;administration to my attending physician; or</span></u></p>

<p class=aMargin1><u><span style='color:black'>………… I have chosen not to
nominate an attending witness, and have been informed of the risks of not
having a witness to attend my self&#8209;administration of the terminal comfort
care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I understand that I have the
right to change my mind at any time and to withdraw or rescind this request and
not to self&#8209;administer the terminal comfort care drug once prescribed.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I undertake to keep the terminal
comfort care drug in a safe and secure place until such time, if ever, when I
decide to self&#8209;administer it.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I undertake not to take the
terminal comfort care drug in a public place, or on the premises of any
hospice, hospital, or other licensed medical or assisted living facility.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I understand that if I decide to
take the terminal comfort care drug, it is my responsibility to self&#8209;administer
it, although someone may assist me in preparing the terminal comfort care drug
for immediate consumption.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I understand that I may have
friends, family, clergy persons, colleagues, or medical practitioners,
including my attending physician or primary care physician, with me if and when
I decide to self&#8209;administer the terminal comfort care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I understand the full import of
this request and I expect to die if I take the terminal comfort care drug to be
prescribed. My attending physician has counseled me about the possibility that
my death may not occur immediately upon the self&#8209;administration of the
drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I make this request voluntarily,
without reservation, and without coercion.</span></u></p>

<p class=aMargin1><u><span style='color:black'>Signed: ……………………………………….</span></u></p>

<p class=aMargin1><u><span style='color:black'>Dated: ………………………………………..</span></u></p>

<p class=aMargin1><u><span style='color:black'>DECLARATION OF WITNESSES</span></u></p>

<p class=aMargin1><u><span style='color:black'>We declare that the person
signing this request meets all of the following criteria:</span></u></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Is personally known to us or has provided proof
of identity.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Voluntarily signed this request in our presence.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Is an individual whom we believe to be mentally
capable and not under duress, fraud, or undue influence.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Is an individual for whom not more than one of
us is the attending physician or mental health specialist.</u></span></p>

<p class=aMargin1><u><span style='color:black'>………………………. Witness 1/Date</span></u></p>

<p class=aMargin1><u><span style='color:black'>………………………. Witness 2/Date</span></u><span
style='color:black'>&quot;</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.3B.  Attending Witness Completion Form.</span></u></p>

<p class=aMargin1><u><span style='color:black'>The Attending Witness Completion
Form given by the attending physician to the qualified individual at the time
the attending physician writes the prescription for a terminal comfort care
drug shall appear in the following form:</span></u></p>

<p class=aMargin1><span style='color:black'>&quot;<u>ATTENDING WITNESS
COMPLETION FORM AFTER SELF&#8209;ADMINISTRATION OF A TERMINAL COMFORT CARE DRUG</u></span></p>

<p class=aMargin1><u><span style='color:black'>I, ………………………………………………, was
nominated by ……………..… (name of qualified individual) ……..….. to be his/her
attending witness at the time of self&#8209;administration of the prescribed terminal
comfort care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>On ……………… (date and time), I
witnessed the self&#8209;administration of said terminal comfort care drug by ………………
(name of qualified individual).</span></u></p>

<p class=aMargin1><u><span style='color:black'>I confirm that …………. (name of
qualified individual) self&#8209;administered the terminal comfort care drug
willingly and without coercion or undue pressure and was aware of his or her
right not to self&#8209;administer the drug at any time.</span></u></p>

<p class=aMargin1><u><span style='color:black'>I confirm that ……………… (qualified
individual) did expire within …….. minutes.</span></u></p>

<p class=aMargin1><u><span style='color:black'>There were no complications
arising during the self&#8209;administration.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(If there were complications,
please describe here:</span></u></p>

<p class=aMargin1><u><span style='color:black'>………………………………………………………………)</span></u></p>

<p class=aMargin1><u><span style='color:black'>I confirm that ………………. did self&#8209;administer
the entire prescription of the terminal comfort care drug, and if the entirety
was not self&#8209;administered, I undertake to ensure that the remaining
prescription is disposed of in a safe and lawful manner.</span></u></p>

<p class=aMargin1><u><span style='color:black'>Signed: ……………………………………….</span></u></p>

<p class=aMargin1><u><span style='color:black'>Dated: ………………………………………..</span></u></p>

<p class=aMargin1><u><span style='color:black'>Time: …………………………………………</span></u><span
style='color:black'>&quot;</span></p>

<p class=aMargin1><u><span style='color:black'>Within 48 hours after the
qualified individual has self&#8209;administered the terminal comfort care
drug, the attending witness shall complete this Attending Witness Completion
Form and timely transmit it to the attending physician.</span></u></p>

<p class=aMargin1><u><span style='color:black'>Upon receiving the Attending
Witness Completion Form, the attending physician shall add it to the medical
records of the qualified individual and include it in his or her transmission
of the Attending Physician Follow&#8209;Up Form to the North Carolina
Department of Health and Human Services.</span></u><span style='color:black'>&quot;</span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.4.  Discontinuation, withdrawal, or
rescission of request.</span></u></p>

<p class=aMargin1><u><span style='color:black'>A qualified individual may at
any time discontinue, withdraw, or rescind his or her request for a terminal
comfort care drug or decide not to self&#8209;administer an terminal comfort
care drug once obtained.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.5.  Attending physician responsibilities.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>No person other than the attending physician may
write a prescription for a terminal comfort care drug. A designee of the
attending physician is not authorized to prescribe a terminal comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Before prescribing a terminal comfort care drug,
the attending physician shall do all of the following:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Make an initial determination that the adult
requesting the terminal comfort care drug meets all of the following qualifications:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>Has the capacity to make medical decisions.</u></span></p>

<p class=aBlock3><u><span style='color:black'>1.</span></u><span
style='color:black'>         <u>If there are indications of a mental disorder
or disease, the physician shall refer the individual for a mental health
specialist assessment.</u></span></p>

<p class=aBlock3><u><span style='color:black'>2.</span></u><span
style='color:black'>         <u>If a mental health specialist assessment
referral is made, no terminal comfort care drugs shall be prescribed unless the
mental health specialist determines that the individual has the capacity to
make medical decisions and is not suffering from impaired judgment due to a
mental disorder or disease.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>Has a terminal disease.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>Has undergone a hospice evaluation which the
attending physician has reviewed along with any records associated with that
evaluation.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>Has voluntarily made the request for a terminal
comfort care drug pursuant to G.S.&nbsp;90&#8209;326.3 and on the form
specified in G.S.&nbsp;90&#8209;326.3A.</u></span></p>

<p class=aBlock2><u><span style='color:black'>e.</span></u><span
style='color:black'>         <u>Is a qualified individual as defined in G.S.&nbsp;90&#8209;326.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Confirm that the individual is making an
informed decision by discussing with him or her all of the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>The individual's medical diagnosis and
prognosis.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>The risks associated with self&#8209;administering
the requested terminal comfort care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>The probable result of self&#8209;administering
the terminal comfort care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>The right of the individual to discontinue the
application for the terminal comfort care drug at any time and the right not to
self&#8209;administer the terminal comfort care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>e.</span></u><span
style='color:black'>         <u>The feasible alternatives or additional end&#8209;of&#8209;life
options.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Confirm that the qualified individual's request
does not arise from coercion or undue influence by another person by discussing
with the qualified individual, outside of the presence of any other persons, except
when a qualified translator is necessary, whether or not the qualified individual
is being coerced or unduly influenced by another person.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Advise the qualified individual of the
importance of the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>Having another person present when the
qualified individual self&#8209;administers the terminal comfort care drug by
nominating an attending witness to be present if and when the qualified individual
decides to self&#8209;administer the terminal comfort care drug, who will be
responsible for (i) completing the Attending Witness Completion Form specified
in G.S.&nbsp;90&#8209;326.3B within 48 hours after the qualified individual has
self&#8209;administered the terminal comfort care drug and (ii) timely transmitting
the Attending Witness Completion Form specified in G.S.&nbsp;90&#8209;326.3B to
the attending physician.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>Not self&#8209;administering the terminal
comfort care drug in a public place or on the premises of any hospice,
hospital, or other licensed medical or assisted living facility.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>Notifying next&#8209;of&#8209;kin of the
qualified individual's request for a terminal comfort care drug and of the
qualified individual's decision to self&#8209;administer the terminal comfort
care drug.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>Maintaining the terminal comfort care drug in a
safe and secure location until the qualified individual decides to self&#8209;administer
it.</u></span></p>

<p class=aBlock2><u><span style='color:black'>e.</span></u><span
style='color:black'>         <u>Properly disposing of the terminal comfort care
drug if the qualified person decides to forego self&#8209;administration.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Offer the qualified individual an opportunity to
withdraw or rescind the request for a terminal comfort care drug before
prescribing the terminal comfort care drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>Inform the qualified individual of the right to
withdraw or rescind the request for a terminal comfort care drug at any time
and in any manner and that the qualified individual is in no way obligated to self&#8209;administer
the terminal comfort care drug once prescribed if the qualified individual changes
his or her mind.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>Verify, immediately prior to writing the
prescription for a terminal comfort care drug, that the qualified individual is
making an informed decision and is in no way acting under undue pressure or
coercion.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>Confirm that all requirements have been met and
all appropriate steps have been carried out in accordance with this Article
before writing a prescription for a terminal comfort care drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(9)</span></u><span
style='color:black'>        <u>Fulfill the documentation requirements of G.S.&nbsp;90&#8209;326.7.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(10)</span></u><span
style='color:black'>      <u>Complete the Attending Physician Checklist and Compliance
Form published by the Department pursuant to G.S.&nbsp;90&#8209;326.17 and
include it in the individual's medical record.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(11)</span></u><span
style='color:black'>      <u>Provide to the qualified individual a copy of the
Attending Witness Completion Form specified in G.S.&nbsp;90&#8209;326.3B in a
self&#8209;addressed, stamped envelope with the instruction that the form
should be completed, executed, and returned to the attending physician by the
attending witness.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>If the conditions set forth in subsection (a) of
this section are satisfied, the attending physician may deliver the terminal
comfort care drug in any of the following ways:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Dispense the terminal comfort care drug directly
to the qualified individual, including ancillary medication intended to
minimize the qualified individual's discomfort, provided that the attending
physician meets all of the following requirements:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>Is authorized under North Carolina law to
dispense controlled substances.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>Has a valid United States Drug Enforcement
Administration registration number and certificate.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>Is in compliance with all applicable State and
federal rules.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>With the qualified individual's written consent,
contact a pharmacist to inform the pharmacist of the prescription and deliver
the written prescription to the pharmacist personally, by mail, or by
electronic transmission. The pharmacist may then dispense the terminal comfort
care drug to the qualified individual, the attending physician, or a person
expressly designated verbally and in writing by the qualified individual to
receive the terminal comfort care drug. The pharmacist shall complete the
Pharmacist Compliance Form published by the Department pursuant to G.S.&nbsp;90&#8209;326.17.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>Delivery of the dispensed drug to the qualified
individual, the attending physician, or a person expressly designated in
writing by the qualified individual may be made by personal delivery or with a
signature required upon delivery, by the United States Postal Service <a
name=4>or other public or private business engaged in the delivery of mail,
packages, or parcels</a>.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.6.  Mental health specialist
responsibilities.</span></u></p>

<p class=aMargin1><u><span style='color:black'>Upon referral from the attending
physician or mental health specialist shall do all of the following:</span></u></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Examine the qualified individual and his or her
relevant medical records.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Determine whether the individual has the mental
capacity to make medical decisions, act voluntarily, and make an informed
decision.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Determine whether the individual is suffering
from impaired judgment due to a mental disorder or disease.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Fulfill the documentation requirements of this
Article.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>Submit in a timely manner to the attending
physician the Mental Health Specialist Compliance Form published by the
Department pursuant to G.S.&nbsp;90&#8209;326.17.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.7.  Documentation requirements.</span></u></p>

<p class=aMargin1><u><span style='color:black'>All of the following shall be
documented in the qualified individual's medical record:</span></u></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>A summary of all verbal requests by the
qualified individual for terminal comfort care drugs, including the date, time,
and location of each request and any tape or digital recording or written
summary of the verbal requests.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>All written requests for terminal comfort care
drugs.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The attending physician's diagnosis and
prognosis and the determination that the individual is a qualified individual
who has the capacity to make medical decisions, is acting voluntarily, and has
made an informed decision, or alternatively that the attending physician has
determined that the individual is not a qualified individual, and why in the
attending physician's judgment the individual is not a qualified individual.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>Confirmation that the individual has undergone a
hospice evaluation.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>A report of the outcome and determinations made
during a mental health specialist's assessment, if performed.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>The attending physician's offer to the qualified
individual to withdraw or rescind his or her request at the time of the
individual's second oral request.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>The Attending Witness Completion Form specified
in G.S.&nbsp;90&#8209;326.3B, if returned to the attending physician completed.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>A note by the attending physician indicating
that all requirements under G.S.&nbsp;90&#8209;326.5 have been met and
indicating the steps taken to carry out the request, including the name and
dosage of the specific terminal comfort care drug prescribed.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.8.  Required submissions to the Department upon
prescribing terminal comfort care drug.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Within 48 hours after writing a prescription for
a terminal comfort care drug, the attending physician shall submit to the
Department a copy of the prescription.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Within 48 hours after dispensing a terminal
comfort care drug, the pharmacist shall submit to the Department a copy of the
Pharmacist Compliance Form published by the Department pursuant to G.S.&nbsp;90&#8209;326.17.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Within 30 calendar days after writing a
prescription for a terminal comfort care drug, the attending physician shall
submit to the Department a copy of the qualifying patient's written request and
the Attending Physician Checklist and Compliance Form published by the
Department pursuant to G.S.&nbsp;90&#8209;326.17.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>Within 30 calendar days after the later of (i)
the qualified individual's death from self&#8209;administering the terminal
comfort care drug or from any other cause or (ii) the date on which the
attending physician receives actual notice of the qualified individual's death
from the Attending Witness Completion Form published by the Department pursuant
to G.S.&nbsp;90&#8209;326.17 or otherwise, the attending physician shall submit
to the Department an Attending Physician Follow&#8209;Up Form published by the
Department pursuant to G.S.&nbsp;90&#8209;326.17.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.9.  Death certificate.</span></u></p>

<p class=aMargin1><u><span style='color:black'>The attending physician may sign
the qualified individual's death certificate. In any event, the cause of death
on a qualified individual's death certificate shall be recorded as the
underlying terminal disease and not the act of self&#8209;administering the
terminal comfort care drug.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.10.  Effect on insurance.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>The sale, procurement, or issuance of any life,
health, or annuity policy, health care service plan contract, or health benefit
plan or the rate charged for any policy, plan contract, or benefit plan shall not
be conditioned upon or affected by the making or rescinding of a person's
request for a terminal comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Consistent with G.S.&nbsp;90&#8209;326.11, death
resulting from the self&#8209;administration of a terminal comfort care drug
shall not be deemed suicide, but rather a hastened death from the underlying terminal
disease, and therefore coverage under a life, health, or annuity policy shall
not be denied, curtailed, or exempted on that basis.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>A qualified individual's act of self&#8209;administering
a terminal comfort care drug shall not have any effect upon a life, health, or
annuity policy other than that of a natural death from the underlying disease.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>An insurance carrier shall not provide any
information in communications to a qualified individual about the availability
of terminal comfort care drugs absent a request by the qualified individual or the
qualified individual's attending physician at the behest of the qualified individual.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.11.  No civil or criminal liability,
penalty, or professional disciplinary action for good&#8209;faith participation
in the activities authorized by this Article.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>A person shall not be subject to civil or
criminal liability or professional disciplinary action for participating in
good&#8209;faith compliance with the activities authorized under this Article
or for being present when a qualified individual self&#8209;administers a terminal
comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>An individual with a terminal disease who self&#8209;administers
a lethal dose of medication shall not be considered a person exposed to grave
physical harm under any Good Samaritan law, and no person shall be subject to
civil or criminal liability solely for being present when an individual with a
terminal disease self&#8209;administers a lethal dose of medication or for failing
to act to prevent the patient from self&#8209;administering a lethal dose of
medication.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>A person who is present when an individual with
a terminal disease self&#8209;administers a terminal comfort care drug may,
without civil or criminal liability, assist the qualified individual at his or
her request by preparing the terminal comfort care drug; provided, however,
that the person does not directly assist the qualified person in self&#8209;administering
the terminal comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>No health care provider, pharmacist, licensing
board, or professional organization or association shall subject an individual
to censure, discipline, suspension, adverse action on a license, loss of
privileges, loss of membership, or other penalty for participating in good&#8209;faith
compliance with the activities authorized under this Article or for refusing to
participate in activities authorized under this Article in accordance with subsection
(e) of this section.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(e)</span></u><span
style='color:black'>        <u>No health care provider or pharmacist shall be
subject to civil, criminal, administrative, disciplinary, employment,
credentialing, professional discipline, contractual liability, or medical staff
action, sanction, penalty, or other liability for participating in the
activities authorized under this Article, including determining the diagnosis
or prognosis of an individual, determining the capacity of an individual for the
purpose of determining if he or she is a qualified individual under this
Article, providing information about this Article to an individual, and
providing a referral to a physician licensed in this State who participates in the
activities authorized under this Article.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.12.  Request for terminal comfort care drug not
a basis for guardianship or claim of neglect or elder abuse.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>A request by a qualified individual to an
attending physician to provide a terminal comfort care drug in good&#8209;faith
compliance with the provisions of this Article shall not provide the basis for
the appointment of a guardian or conservator.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>No actions taken in compliance with the
provisions of this Article shall constitute or provide the basis for any claim
of neglect or elder abuse for any purpose of law.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.13.  Voluntary nature of authorized
activities under this Article.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Participation in activities authorized under
this Article is strictly voluntary. A person or entity that elects, for reasons
of conscience, morality, or ethics, not to engage in activities authorized under
this Article is not required to take any action in support of another
individual's decisions or actions under this Article. Except as provided in
subsection (d) of this section, a person or entity that elects not to engage in
such activities shall not impede or interfere with a qualified individual's
decision to self&#8209;administer a terminal comfort care drug.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>No health care provider or pharmacist shall be
subject to civil, criminal, administrative, disciplinary, employment,
credentialing, professional discipline, contractual liability, or medical staff
action, sanction, penalty, or other liability for refusing to participate in
activities authorized under this Article.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>If a health care provider or pharmacist is
unable or unwilling to carry out an individual's request under this Article and
the individual transfers care to a new health care provider, the individual may
request that a copy of his or her medical records be sent directly to the
individual or to the new health care provider.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>A health care provider may prohibit its
employees, independent contractors, or other persons or entities, including
other health care providers, from participating in activities authorized under
this Article while on premises owned or under the management or direct control
of that health care provider, or while acting within the course and scope of
any employment by, or contract with, that health care provider.</u></span></p>

<p class=aMargin1><u><span style='color:black'>A health care provider that elects
to prohibit its employees, independent contractors, or other persons or
entities, including health care providers, from participating in activities authorized
under this Article shall first give notice of the policy prohibiting
participation under this Article to the individuals or entities prohibited from
participating in such activities. A health care provider that fails to provide such
prior notice of its policy shall not be entitled to enforce the policy against any
individual or entity.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.14.  Impermissible sanctions.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>A health care provider may not be sanctioned for
any of the following:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>Making an initial determination pursuant to the
standard of care that an individual has a terminal disease and informing him or
her of the medical prognosis.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>Providing information about the End of Life Option
Act to an individual upon inquiry.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>Providing an individual, upon request, with a
referral to another physician.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>An entity that prohibits activities authorized under
this Article in accordance with G.S.&nbsp;90&#8209;326.14 shall not sanction an
individual health care provider for contracting with a qualified individual to
engage in activities authorized under this Article if the individual health
care provider is acting outside the course and scope of his or her employment
or contract with the entity prohibiting such activities.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>The protection from sanctions described in this
section is solely reserved for health care providers who engage in actions
authorized under this Article.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.15.  Felonious activities.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>Knowingly altering or forging a request for a terminal
comfort care drug to hasten an individual's death without that individual's authorization,
concealing or destroying a withdrawal or rescission of a request for a terminal
comfort care drug, destroying or concealing an individual's written request for
a terminal comfort care drug, or concealing or destroying an individual's
prescribed terminal comfort care drug is punishable as a felony if the act is
done with the intent or effect of causing, interfering with, or preventing the
individual's death against his or her wishes.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Knowingly coercing or exerting undue influence
on an individual to request or self&#8209;administer a terminal comfort care
drug for the purpose of ending his or her life or knowingly destroying a
withdrawal or rescission of a request or administering a terminal comfort care
drug to an individual without his or her knowledge or consent is punishable as
a felony.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(c)</span></u><span
style='color:black'>        <u>Knowingly coercing or exerting undue influence
to interfere with an individual's expressed desire to hasten his or her death
by self&#8209;administration of a prescribed terminal comfort care drug is
punishable as a felony.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(d)</span></u><span
style='color:black'>       <u>Nothing in this section shall be construed to
limit civil liability for acts or omissions of gross negligence or intentional
misconduct.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(e)</span></u><span
style='color:black'>        <u>The penalties in this section do not preclude
criminal penalties applicable under other provisions of law for conduct
inconsistent with the provisions of this Article.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.16.  Department to collect information;
information to remain confidential and is not a public record.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>The Department shall collect and review the
information submitted pursuant to G.S.&nbsp;90&#8209;326.8. The information
collected and maintained by the Department pursuant to G.S.&nbsp;90&#8209;326.8
and this section is confidential and not a public record under G.S.&nbsp;132&#8209;1.
The Department shall collect and maintain this information in a manner that
protects the privacy of the qualified individual, the qualified individual's
family, and any participating health care provider or pharmacist.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Annually, on or before April 15, the Department
shall create and make available to the general public on the Department's Internet
Web site a report based on the information collected by the Department pursuant
to G.S.&nbsp;90&#8209;326.8 and this section during the preceding calendar year.
The report shall include at least all of the following based on the information
provided to the Department pursuant to G.S.&nbsp;90&#8209;326.8 and this
section and the Department's access to vital statistics:</u></span></p>

<p class=aBlock1><u><span style='color:black'>(1)</span></u><span
style='color:black'>        <u>The number of individuals who initiated
procedures to obtain a terminal comfort care drug under this Article.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(2)</span></u><span
style='color:black'>        <u>The number of individuals for whom a terminal
comfort care drug was prescribed.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(3)</span></u><span
style='color:black'>        <u>The number of known individuals who died each
year for whom a terminal comfort care drug was prescribed and the cause of
death for each of these individuals.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(4)</span></u><span
style='color:black'>        <u>For the preceding calendar year, the cumulative
totals of all the following:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>The number of prescriptions written for terminal
comfort care drugs.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>The number of people who died as a result of self&#8209;administering
a terminal comfort care drug.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(5)</span></u><span
style='color:black'>        <u>The number of known deaths in North Carolina hastened
by terminal comfort care drugs per 10,000 deaths in North Carolina and by
natural causes per 10,000 deaths.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(6)</span></u><span
style='color:black'>        <u>The number of physicians licensed in this State who
wrote prescriptions for terminal comfort care drugs.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(7)</span></u><span
style='color:black'>        <u>The number of pharmacists participating in
activities authorized under this Article.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(8)</span></u><span
style='color:black'>        <u>The names and dosages of prescribed terminal
comfort care drugs.</u></span></p>

<p class=aBlock1><u><span style='color:black'>(9)</span></u><span
style='color:black'>        <u>Of the individuals who died as a result of self&#8209;administering
a terminal comfort care drug, demographic percentages organized by the
following characteristics:</u></span></p>

<p class=aBlock2><u><span style='color:black'>a.</span></u><span
style='color:black'>         <u>Age at death.</u></span></p>

<p class=aBlock2><u><span style='color:black'>b.</span></u><span
style='color:black'>         <u>Education level.</u></span></p>

<p class=aBlock2><u><span style='color:black'>c.</span></u><span
style='color:black'>         <u>Race.</u></span></p>

<p class=aBlock2><u><span style='color:black'>d.</span></u><span
style='color:black'>         <u>Sex.</u></span></p>

<p class=aBlock2><u><span style='color:black'>e.</span></u><span
style='color:black'>         <u>Type of insurance, including whether or not the
individual had insurance coverage.</u></span></p>

<p class=aBlock2><u><span style='color:black'>f.</span></u><span
style='color:black'>          <u>Underlying terminal disease.</u></span></p>

<p class=aBlock2><u><span style='color:black'>g.</span></u><span
style='color:black'>         <u>The number of days elapsed between the date the
prescription was filled and the date the prescription was self&#8209;administered
and resulted in death.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.17.  Department to develop, update, and
publish forms.</span></u></p>

<p class=aMargin1><u><span style='color:black'>The Department shall develop an
Attending Physician Checklist and Compliance Form, an Attending Physician Follow&#8209;Up
Form, a Mental Health Specialist Compliance Form, a Pharmacist Compliance Form,
and any other form the Department deems necessary to implement the provisions
of this Article, provided, however, that any form the Department develops pursuant
to this section shall be consistent with the requirements of this Article. The
Department shall, as necessary, update and publish all forms to be used under
this Article on its Internet Web site in a format that can be downloaded by the
general public.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.18.  Disposal of terminal comfort care drugs
after death of qualified individual.</span></u></p>

<p class=aMargin1><u><span style='color:black'>A person who has custody or
control of any unused terminal comfort care drugs prescribed pursuant to this Article
after the death of a qualified individual shall (i) personally deliver the
unused terminal comfort care drugs for disposal at the nearest qualified
facility that properly disposes of controlled substances, or if none is
available, (ii) dispose of the terminal comfort care drug by lawful means in
accordance with rules adopted by the North Carolina State Board of Pharmacy or
a federal Drug Enforcement Administration approved take&#8209;back program.</span></u></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.19.  Construction of Article.</span></u></p>

<p class=aMargin1><u><span style='color:black'>(a)</span></u><span
style='color:black'>        <u>This Article shall not be construed to authorize
a physician or any other person to end an individual's life by lethal
injection, mercy killing, or active euthanasia.</u></span></p>

<p class=aMargin1><u><span style='color:black'>(b)</span></u><span
style='color:black'>        <u>Actions taken in accordance with this Article
shall not, for any purposes, constitute suicide, assisted suicide, homicide, or
elder abuse under the laws of North Carolina.</u></span></p>

<p class=aSection><span style='color:black;font-weight:normal'>&quot;</span><u><span
style='color:black'>§ 90&#8209;326.20.  Severability of provisions.</span></u></p>

<p class=aMargin1><u><span style='color:black'>If any provision of this Article
or the application of this Article to any person or circumstances is for any
reason held invalid, such invalidity shall not affect other provisions or
applications of this Article that can be given effect without the invalid
provision or application, and to this end the provisions of this Article are
declared to be severable.</span></u><span style='color:black'>&quot;</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.(a)</span></b><span
style='color:black'>  By December 31, 2019, the Department of Health and Human
Services shall develop and publish to its Internet Web site, in downloadable format,
the forms described in G.S.&nbsp;90&#8209;326.17, as enacted by this act.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.(b)</span></b><span
style='color:black'>  The first report required by the Department under
G.S.&nbsp;90&#8209;326.16(b), as enacted by this act, is due and shall be
published on its Internet Web site on or before March 15, 2021.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 2.(c)</span></b><span
style='color:black'>  This section is effective when this act becomes law.</span></p>

<p class=aBillSection><b><span style='color:black'>SECTION 3.</span></b><span
style='color:black'>  Except as otherwise provided, this act becomes effective
December 1, 2019, and applies to offenses committed on or after that date.</span></p>

</div>

</body>

</html>
